AI-Powered Medical Devices

Lunit, a Seoul-based AI medical imaging company, has FDA-cleared products for AI-assisted detection of breast cancer (Lunit INSIGHT MMG), lung nodules, and other pathologies from X-ray and CT images. The company's technology is deployed in over 4,000 hospitals across 50+ countries, with clinical studies showing it improves radiologist cancer detection rates by 10-20%. Vuno and Coreline Soft are comparable Korean companies with their own FDA-cleared AI diagnostic products.

Korea's medical AI companies benefit from the country's universal healthcare system, which generates large, standardized medical imaging datasets ideal for training AI models. Korean hospitals are among the most digitized in the world, with near-complete electronic health record adoption and PACS (picture archiving) systems that provide the data infrastructure AI companies need.

Lunit went public on KOSDAQ in 2022 and has established partnerships with GE Healthcare, Philips, and Fujifilm for integration into their imaging platforms. The Korean medical device sector is small compared to the US or Germany but growing rapidly, driven by AI diagnostics, robotic surgery systems (Revo Surgical's single-port robot), and telemedicine platforms developed during and after COVID-19.